Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT
NCT03172910
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Ciraparantag
DRUG:
Placebo
DRUG:
Rivaroxaban
Sponsor
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.